Glaucoma trials in United States

In United States 98 Also abroad 240

98 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Effect of Late Ripcord Removal From Glaucoma Drainage Device
Where
Durham
Age
18 years and over
People
80
Run by
Duke University
See details and how to joinNCT07803536
No phaseNot yet taking people in United States
PureSee EDOF Versus ZCB00 Monofocal IOLs in Mild-to-Moderate Glaucoma
Where
Houston
Age
45 years and over
People
100
Run by
Mann Eye Institute
See details and how to joinNCT07924215
No phaseTaking people
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Where
Birmingham
Age
18 years and over
People
1,800
Run by
University of Alabama at Birmingham
See details and how to joinNCT06629649
No phaseTaking people
Automated Applanation Tonometry - Updated
Where
Durham
Age
18 years and over
People
200
Run by
Duke University
See details and how to joinNCT07298356
Phase 2Taking people
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
Where
Glendale, Lynchburg, Newport Beach
Age
18 years and over
People
96
Run by
Tavo Biotherapeutics
See details and how to joinNCT07913074
No phaseNot yet taking people in United States
Glaucoma Drop Aids Part 2
Where
Boston
Age
18 years and over
People
80
Run by
Boston Medical Center
See details and how to joinNCT06806332
Phase 4Taking people
Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients
Where
Bloomington
Age
18 years and over
People
13
Run by
Brett King
See details and how to joinNCT07847073
Phase 2Not yet taking people in United States
VGFTe-(HD)-OD-2566: Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study
Where
Miami
Age
18 years to 85 years
People
100
Run by
University of Miami
See details and how to joinNCT07891182
Phase 4Not yet taking people in United States
Iopidine to Decrease Intraocular Pressure Rise After Injections
Where
Easton
Age
18 years and over
People
120
Run by
Retina Consultants of Delmarva
See details and how to joinNCT07891910
Phase 1/2Taking people
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
Where
Boston
Age
18 years and over
People
156
Run by
Astellas Pharma Global Development, Inc.
See details and how to joinNCT07770685
Phase 1Taking people
Topical Insulin for Glaucoma
Where
Palo Alto
Age
18 years and over
People
52
Run by
Stanford University
See details and how to joinNCT05206877
No phaseTaking people
Glaucoma Screening to Enhance At-Risk Californians' Health
Where
Fremont, Oakland, San Francisco
Age
50 years and over
People
2,000
Run by
University of California, San Francisco
See details and how to joinNCT06854198
Phase 4Not yet taking people in United States
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
Where
New Orleans
Age
18 years and over
People
60
Run by
Tulane University
See details and how to joinNCT04007276
No phaseEnrolling by invitation
A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma
Where
Alexandria, Buffalo, Chico, Coon Rapids, Cranberry Township, Dallas, El Paso, Medford, Petaluma
People
300
Run by
Iantrek, Inc.
See details and how to joinNCT07520175
Phase 1/2Enrolling by invitation
Topical Insulin for Glaucoma (TING2)
Where
Palo Alto
Age
18 years to 90 years
People
90
Run by
Stanford University
See details and how to joinNCT07619482
Phase 2Not yet taking people in United States
Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)
Where
Chicago
Age
40 years to 80 years
People
96
Run by
University of Chicago
See details and how to joinNCT07808333
No phaseTaking people
Hyperbaric Oxygen Therapy for Optic Neuropathies
Where
Palo Alto
Age
18 years and over
People
60
Run by
Stanford University
See details and how to joinNCT06128720
No phaseTaking people
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
Where
Palo Alto
Age
18 years and over
People
30
Run by
Stanford University
See details and how to joinNCT06685211
Phase 3Taking people
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Where
Aurora, Bala-Cynwyd, Brandon, Charlottesville, Cincinnati, Cleveland, Colorado Springs, Culver City, Dallas, El Paso, Fraser, Glendale, Houston, Jacksonville, Kenosha, Minneapolis, New Orleans, New York, Oklahoma City, Omaha, Overland Park, Peoria, Petaluma, Philadelphia, Reading, Roanoke, Roswell, Vero Beach
Age
45 years and over
People
130
Run by
AbbVie
See details and how to joinNCT06822738
No phaseTaking people
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Where
Dallas, Glendale, Grand Junction, Houston, Kenosha, Los Angeles, New York, Petaluma, Philadelphia, Sacramento
Age
45 years and over
People
165 worldwide
Run by
Avisi Technologies Inc.
See details and how to joinNCT07220876
No phaseTaking people
Comparative Study of the Tomey FT-1000, and Goldmann Applanation Tonometer (GAT)
Where
Jacksonville
Age
22 years and over
People
30
Run by
Tomey Corporation
See details and how to joinNCT07804277
No phaseTaking people
iDose TR Administration in an Office-Based Surgery Setting
Where
Austin
Age
18 years and over
People
30
Run by
Glaukos Corporation
See details and how to joinNCT07816692
Phase 1/2Taking people
REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Where
Deerfield Beach
Age
18 years and over
People
271
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07675824 · EU 2026-526004-76-00
Phase 3Taking people
A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
Where
Beverly Hills, Boynton Beach, Houston, Inglewood, Louisville, Morrow, Newport Beach, Petaluma, Roswell, San Antonio, St Louis, Weston
Age
18 years and over
People
600 worldwide
Run by
YS Life Science Co., Ltd.
See details and how to joinNCT07661329
No phaseTaking people
Hydrus® Microstent New Enrollment Post-Approval Study
Where
Austin, Brecksville, Chesterfield, Cincinnati, Coon Rapids, Cranberry Township, Dallas, El Paso, Fraser, Hurst, Irvine, Kansas City, Kenosha, Las Vegas, Loveland, Mason, Overland Park, Rockville, Sacramento, Salt Lake City, Sioux City, Southern Pines
Age
45 years and over
People
545
Run by
Alcon Research
See details and how to joinNCT04553523